HemaSphere (Jun 2022)

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

  • P. L. Zinzani,
  • M. Özcan,
  • K. Sapunarova,
  • W. Jurczak,
  • A. Hamed,
  • K. Bouabdallah,
  • G. Saydam,
  • K. Geissler,
  • Á. Szomor,
  • M. Lazaroiu,
  • A. Salar,
  • A. Tempescul,
  • M. Nalcaci,
  • L. Gercheva,
  • M. Egyed,
  • P. Panayiotidis,
  • L. Mongay Soler,
  • A. Cao,
  • C. Phelps,
  • B. H Childs,
  • M. J Matasar

DOI
https://doi.org/10.1097/01.HS9.0000847420.24995.43
Journal volume & issue
Vol. 6
pp. 1028 – 1029

Abstract

Read online

No abstracts available.